Fundz

Genie Therapeutics reported raising $50,000 in an initial SEC Form D filing

PRIVATEJul 27, 2023

Amount Raised

$50,000

$50,000 sold, per SEC Form D (first sale Jul 10, 2023)

Round Type

Pre-Seed

WilmingtonBiotechnology

Who to call at GENIE Therapeutics, and when

A new round usually means GENIE Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GENIE Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GENIE Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GENIE Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GENIE Therapeutics

Location

1207 DELAWARE AVENUE #1118

Wilmington, Delaware, United States

About

GENIE Therapeutics is currently launching multiple gene therapies through the FDA pipeline. This breakthrough platform developed with Johns Hopkins, and NIH funding, has blockbuster potential. With revolutionizing aesthetics, it can be used across all full-body aesthetic skin conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GENIE Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for GENIE Therapeutics's next move

See what Strategic adds

GENIE Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.